Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  12/31/1969
Premier Urology Group
mi
from
New York, NY
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 12/31/1969
Premier Urology Group
mi
from
New York, NY
Click here to add this to my saved trials
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  12/31/1969
Winthrop University
mi
from
Garden City, NY
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 12/31/1969
Winthrop University
mi
from
Garden City, NY
Click here to add this to my saved trials
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Urology Associates PC
mi
from
Englewood, CO
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Urology Associates PC
mi
from
Englewood, CO
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Houston Metro Urology
mi
from
Houston, TX
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Houston Metro Urology
mi
from
Houston, TX
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Urology Centers of Alabama, PC
mi
from
Birmingham, AL
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Urology Centers of Alabama, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Royal Melbourne Hospital
mi
from
Melbourne,
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Royal Melbourne Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
San Diego Clinical Trials
mi
from
San Diego, CA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
San Diego Clinical Trials
mi
from
San Diego, CA
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Adult and Pediatric Urology P.C
mi
from
Omaha, NE
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Adult and Pediatric Urology P.C
mi
from
Omaha, NE
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Virginia Urology
mi
from
Richmond, VA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Virginia Urology
mi
from
Richmond, VA
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
University of Southern California, Institute of Urology
mi
from
Los Angeles, CA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
University of Southern California, Institute of Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Anniston, AL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Anniston, AL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
San Diego, CA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
San Diego, CA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Aventura, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Aventura, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Clearwater, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Clearwater, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Coral Gables, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Deland, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Deland, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Hialeah, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Ocala, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Avon, IN
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Avon, IN
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Wichita, KA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Greenbelt, MD
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Greenbelt, MD
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Omaha, NE
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Englewood, NJ
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Albuquerque, NM
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Garden City, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Garden City, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
New York, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Newburgh, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Newburgh, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Poughkeepsie, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Concord, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Concord, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
High Point, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
High Point, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Raleigh, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Wilmington, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Winston-Salem, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Akron, OH
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Warwick, RI
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Warwick, RI
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Charleston, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Greer, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Greer, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Mount Pleasant, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Houston, TX
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
San Antonio, TX
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Clinton, UT
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Clinton, UT
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
mi
from
Ogden, UT
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
mi
from
Ogden, UT
Click here to add this to my saved trials